{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:57:06Z","timestamp":1779933426590,"version":"3.53.1"},"reference-count":32,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance:<\/jats:title>\n                    <jats:p>Owing to its anti-inflammatory properties and antiviral \u201cin vitro\u201d effect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cannabidiol (CBD) has been proposed as a potential treatment for coronavirus disease 2019 (COVID-19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To investigate the safety and efficacy of CBD for treating patients with mild to moderate COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Randomized, parallel-group, double-blind, placebo-controlled clinical trial conducted between July 7 and October 16, 2020, in two sites in Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Patients were recruited in an emergency room.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants:<\/jats:title>\n                    <jats:p>Block randomized patients (1:1 allocation ratio\u2014by a researcher not directly involved in data collection) with mild and moderate COVID-19 living in Ribeir\u00e3o Preto, Brazil, seeking medical consultation, and those who voluntarily agreed to participate in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Patients received 300\u2009mg of CBD or placebo added to standard symptomatic care during 14 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome and Measure:<\/jats:title>\n                    <jats:p>The primary outcome was reduction or prevention of the deterioration in clinical status from mild\/moderate to severe\/critical measured with the COVID-19 Scale or the natural course of the resolution of typical clinical symptoms. Primary study outcome was assessed on days 14, 21, and 28 after enrollment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 321 patients were recruited and assessed for eligibility, and 105 were randomly allocated either in CBD (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =49) or in placebo (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =42) group. Ninety-one participants were included in the analysis of efficacy. There were no baseline between-group differences regarding disease severity (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      =0.025,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.988) and median time to symptom resolution (12 days [95% confidence interval, CI, 6.5\u201317.5] in the CBD group, 9 days [95% CI, 4.8\u201313.2] in the placebo group [\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      =1.6,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.205 by log-rank test]). By day 28, 83.3% in the CBD group and 90.2% in the placebo group had resolved symptoms. There were no between-group differences on secondary measures. CBD was well tolerated, producing mostly mild and transient side effects (e.g., somnolence, fatigue, changes in appetite, lethargy, nausea, diarrhea, and fever), with no significant differences between CBD and placebo treatment groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance:<\/jats:title>\n                    <jats:p>\n                      Daily administration of 300\u2009mg CBD for 14 days failed to alter the clinical evolution of COVID-19. Further trials should explore the therapeutic effect of CBD in patients with severe COVID-19, possibly trying higher doses than the used in our study. Trial Registration:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      identifier NCT04467918 (date of registration: July 13, 2020).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2021.0093","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T17:02:13Z","timestamp":1633798933000},"page":"658-669","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":25,"title":["Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial"],"prefix":"10.1177","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-6746","authenticated-orcid":false,"given":"Jos\u00e9 Alexandre S.","family":"Crippa","sequence":"first","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."},{"name":"National Institute for Science and Technology\u2014Translational Medicine, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Cozar","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio W.","family":"Zuardi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."},{"name":"National Institute for Science and Technology\u2014Translational Medicine, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"National Institute for Science and Technology\u2014Translational Medicine, S\u00e3o Paulo, Brazil."},{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alline Cristina","family":"Campos","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via de Lima","family":"Os\u00f3rio","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."},{"name":"National Institute for Science and Technology\u2014Translational Medicine, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Regina","family":"Loureiro","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael G.","family":"dos Santos","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."},{"name":"National Institute for Science and Technology\u2014Translational Medicine, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Diogo S.","family":"Souza","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Mayumi","family":"Ushirohira","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Rinaldi","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Cristinne","family":"Mancini Costa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davi Silveira","family":"Scomparin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciele Franco","family":"Scarante","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Pires-Dos-Santos","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Natural Products, The Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"additional","affiliation":[{"name":"National Institute for Science and Technology\u2014Translational Medicine, S\u00e3o Paulo, Brazil."},{"name":"Department of Psychiatry and Behavioural Neurosciences, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."},{"name":"Graduate Program in Psychiatry and Behavioral Sciences, Department of Psychiatry, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedito A.L.","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danillo L.A.","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afonso Dinis Costa","family":"Passos","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury Lelis","family":"Dal Fabbro","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bellissimo-Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eurico","family":"Arruda","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Biology, and Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Scarpelini","sequence":"additional","affiliation":[{"name":"Department of Surgery and Anatomy, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristela Haddad","family":"Andraus","sequence":"additional","affiliation":[{"name":"Chromatox Laboratory Ltda., S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Cesar","family":"Nather Junior","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Tadao","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Koenigkam-Santos","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo","family":"Busatto Filho","sequence":"additional","affiliation":[{"name":"Laboratory of Psychiatric Neuroimaging (LIM 21), Department of Psychiatry, Faculty of Medicine, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E.C.","family":"Hallak","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavior, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."},{"name":"National Institute for Science and Technology\u2014Translational Medicine, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Cannabidiol for COVID-19 Patients (CANDIDATE) Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000510799"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.079"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15157"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2019.0060"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041986"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.613613"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0043"},{"key":"e_1_3_6_9_2","first-page":"251","article-title":"Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome","volume":"843","author":"Khodadadi H","year":"2019","unstructured":"Salles \u00c9L, Khodadadi H, , Jarrahi A, et al. Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome. J Cell Mol Med. 2019; 843:251\u2013259.","journal-title":"J Cell Mol Med"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2014.12.051"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2013.06.016"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23738"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.09.014"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81049-2"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.11.029"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.12.020"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00521.x"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.08.012"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712001502"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.6"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.02466"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001405"},{"key":"e_1_3_6_23_2","unstructured":"China NHC . New Coronavirus Pneumonia Prevention and Control Protocol . 7th ed. National Health Commission of the People's Republic of China; 2020. http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202003\/46c9294a7dfe4cef80dc7f5912eb1989\/files\/ce3e6945832a438eaae415350a8ce964.pdf (accessed March5 2020)."},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775"},{"key":"e_1_3_6_25_2","unstructured":"World Health Organization. WHO R&D blueprint: novel coronavirus: COVID-19 therapeutic trial synopsis. https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf (accessed June28 2020)."},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.06.033"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00990-2020"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1109\/RBME.2020.2990959"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.9788\/TP2016.1-25"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-6163.2009.00224.x"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.006"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13404"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02009"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2021.0093","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0093","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:25Z","timestamp":1777385485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2021.0093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10,1]]}},"alternative-id":["10.1089\/can.2021.0093"],"URL":"https:\/\/doi.org\/10.1089\/can.2021.0093","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}